| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 09/18/2003 | US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |
| 09/18/2003 | US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/11/2003 | US20030171345 8Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivatives |
| 09/04/2003 | WO2003072555A1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments |
| 09/04/2003 | CA2477031A1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 09/03/2003 | EP0775156B1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 08/28/2003 | WO2003070194A2 Amino acid and peptide-modified forms of glucocorticoids |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/26/2003 | US6610675 Inactive metabolite approach to soft drug design |
| 08/26/2003 | US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers |
| 08/21/2003 | US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 08/19/2003 | US6608074 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 08/14/2003 | US20030153543 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/07/2003 | WO2003064443A2 New corticosteroids |
| 08/07/2003 | CA2473249A1 New corticosteroids |
| 08/05/2003 | CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
| 07/31/2003 | WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 07/30/2003 | EP1331011A2 Derivatized oligonucleotides having improved uptake and other properties |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/17/2003 | US20030134834 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/15/2003 | US6593301 Ligosaccharide glycosides derived from spirostane with high effective and low side action wherein the dementia is Alzheimer's disease, vascular dementia, or mixed type dementia |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/02/2003 | EP1322660A2 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/24/2003 | US6583131 Cationic cholesteryl derivatives containing cyclic polar groups |
| 06/19/2003 | US20030113265 Contrast agents for magnetic resonance imaging |
| 06/05/2003 | WO2003045972A1 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS |
| 06/03/2003 | US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability |
| 06/03/2003 | CA2332652C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/27/2003 | US6569844 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/22/2003 | US20030097011 Novel carbamate-based cationic lipids |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/20/2003 | US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol |
| 05/15/2003 | US20030092690 Administering by inhalation |
| 05/14/2003 | EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 05/07/2003 | EP0724447B1 Derivatized oligonucleotides having improved uptake |
| 05/02/2003 | EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 05/02/2003 | EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 05/01/2003 | WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/24/2003 | WO2002066490A3 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 04/17/2003 | US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/16/2003 | EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/16/2003 | EP1060187B1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/15/2003 | US6548491 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/10/2003 | US20030069434 Antiestrogenic properties or tissue-selective estrogenic properties |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 03/27/2003 | WO2003024940A1 Bifunctional chelating agent for actinium |
| 03/25/2003 | US6537983 Anti-inflammatory androstane derivatives |
| 03/19/2003 | EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 03/11/2003 | US6531584 Nuclease resistant oligonucleotide analogs; DNA or RNA modulation; diagnosis, thearpy of viral diseases |
| 03/06/2003 | US20030045512 Androstanecarbothioic acid derivatives, especially esterified with thazol-5-ylcarboxylic acid; formulation for administration by inhalation |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/19/2003 | EP1284272A1 Estra-1,3,5(10)-triene derivatives |
| 02/12/2003 | EP1042355B1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments |
| 02/12/2003 | EP1032584B1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/06/2003 | WO2003009853A1 Methods for preventing antipsychotic-induced weight gain |
| 02/06/2003 | US20030027802 Methods for preventing antipsychotic-induced weight gain |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 01/30/2003 | US20030022874 New 17-halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them |
| 01/29/2003 | EP1278763A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 01/28/2003 | CA2094300C Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
| 01/21/2003 | US6509462 Biotinylated estradiol provides labeled compound for immunoassay for 17-beta-estradiol and estrone |
| 01/15/2003 | EP0754178B1 Novel functionalized hydrophilic acridinium esters |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/07/2003 | US6503896 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 01/07/2003 | US6503895 Antigestagenically active steroids with a fluorinated 17α-alkyl chain |
| 01/03/2003 | WO2002066489A3 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004148 Regulation of meiosis |
| 01/02/2003 | EP1267898A2 Bile acid containing prodrugs with enhanced bioavailability |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/18/2002 | EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 12/12/2002 | US20020188143 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds |
| 12/12/2002 | US20020187971 Hybrid cholinergic agents and compositions, methods of making, and methods of using to treat a cholinergic disorder |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/10/2002 | CA2084314C Starting compounds for the production of 10beta-h steroids and process for producing such starting compounds |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 12/05/2002 | US20020183295 For therapy of psychotic disorders, pain, sleep disorders, depression, Alzheimer's disease, tardive dyskinesia, Picks disease, Huntington's chorea, Frederic's ataxia, Gilles de la Pteriidae's disease, Down's Syndrome |
| 12/05/2002 | US20020183283 Meiosis regulating compounds |
| 11/27/2002 | EP1259532A1 Bile acids conjugates with metal ion chelates and the use thereof |
| 11/21/2002 | WO2002092631A1 Kinetic assay |